chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was administered with vaccine that was beyond use date after the thaw process; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered with vaccine that was beyond use date after the thaw process) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 27-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 27-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered with vaccine that was beyond use date after the thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered with vaccine that was beyond use date after the thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that the age of patient was 57  years 11 months. No concomitant medications were reported It was unknown if patient had acute illness at the time of vaccination and up to one month before. It was unknown if patient had been diagnosed with or tested positive for COVID-19, nor if patient had chronic or long lasting health conditions. Patient had reported no adverse reactions after the administration of vaccine. Treatment details was not reported by the reporter.
Patient received Moderna instead of Pfizer.  Pfizer was administered on 01/28/2021.  Patient was accidentally administered Moderna on follow up for second dose on 2/24/2021.  The health department was contacted regarding the error and we were advised to document and that the patient would not receive a second dose of Pfizer.  The moderna vaccine would count as her second dose in the series.  All of this was explained to the patient.  She did not have any adverse events aside from a sore arm for about 24 hours after injection.
Adnopathy  Headache  Intermittent fever O2 sat fluctuates between 84-92% Joint pain  Fatigued
The evening after getting my second dose, i became disoriented and lost my ability to walk.  Had to lay down in the garage as I was unable to make it inside.   Was there between 15-30 minutes,  (couldn't tell how long) had problems speaking and had uncontrollable limb movement.  It  felt  like what I would think a seizure or stroke would be like.  NO pain, just told my husband i was dying and to call the kids.
pt recvd vax 8DEC93 & a couple of hrs following the vax exp a severe h/a w/malaise, nausea & vomiting; No further details were provided
very tender; limited range of motion in neck due to pain.; 30Apr2021 lymph node extremely painful to touch; lymph node the size of a golf ball within 6hrs after injection; This is a spontaneous report from a contactable other health care professional (patient). A 34-year-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: Ew0161), via an unspecified route of administration, administered in left arm on 29Apr2021 (at the age of 34 years) as dose 2, single for COVID-19 immunization. The patient's medical history included allergy to pears. The patient's concomitant medications were not reported. The patient did not receive other vaccine in four weeks. The patient did not receive other medications in two weeks. The patient did not have COVID prior vaccination. The patient did not get COVID tested post vaccination. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ER8730), via an unspecified route of administration, administered in left arm on 06Apr2021 10:00 (at the age of 34 years) as dose 1, single for COVID-19 immunization and noticed swollen lymph node after 1 week, was smaller but still noticeable. On 29Apr2021 lymph node the size of a golf ball within 6hrs after injection on 30Apr2021 lymph node extremely painful to touch and limited range of motion in neck due to pain on an  unspecified date patient experienced very tender. It was reported that Swollen lymph node above collarbone on same side as injection after both doses. Very swollen and very tender after 2nd dose. Received 2nd dose 29Apr2021, lymph node the size of a golf ball within 6hrs after injection. 30Apr2021 lymph node extremely painful to touch, limited range of motion in neck due to pain. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Approx. 2 days after MMR pt. developed severe polyarthritis of multiple joints. The patient is a 56 year old female who presents with a hip problem. Note for "Hip problem": R hips is swollen. Went to ER after getting MMR a couple of weeks ago with swelling in both hips. Now just both hips/ mostly upper leg area/ elbows and knees. Additional reasons for visit: Sore throat is described as the following: The sore throat has been occurring for 1 week. The course has been worsening. There had been no associated chills or fever. Note for "Sore throat": Patient says it felt like a lymph node on R side of neck.
12 hours post injection developed chills 14 hours post injection develop fever 99.9, which resolved by the next morning (27 hours post-injection) Did not have any adverse effects with first dose in series
Began to experience UTI type symptoms, with uncharacteristically frequent urination, and some burning. Began to have a fever which over the 24 hour period went from my normal of 97.6 to 101.2 at 10:30pm the second night. Throughout the period I had a mild headache and significant fatigue. I woke up this morning at 12:30am with the sheets, pillow and pajamas very wet (from sweat). I checked my temperature and for the first time in 24 hours, it had dropped (to 99.2). When I got up at 6 this morning, my temperature was 98.6 (still a little elevated for me). My wife experienced practically the same thing 4 days earlier without the urinary symptoms and temp not quite a elevated. We had the vaccine at the same time(s). I'm still fairly fatigued at this time (and my wife a little).
Tinnitus went from low barely noticeable to very severe; This spontaneous case was reported by an other and describes the occurrence of TINNITUS (Tinnitus went from low barely noticeable to very severe) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Tinnitus.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced TINNITUS (Tinnitus went from low barely noticeable to very severe). At the time of the report, TINNITUS (Tinnitus went from low barely noticeable to very severe) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Company Comment  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Approximately 12 hours after vaccination developed fever 102.8, headache, severe nausea and joint pain in hands knees and ankles. Symptoms resolved within 48 hours except for joint pain in hands.
Patient came in for first dose of Moderna vaccine. He reported no previous allergic reactions in the past. Once the patient received a vaccine, he was instructed to wait for 15 minutes. Close to the 15 minute mark, patient described  his arm and face feeling "hot and a bit heavy" on the side he received the vaccine. Patient reported no swelling of the throat or face area. He had no trouble breathing. Patient did report he was experiencing some dry mouth. I assessed the patient for any rash, redness or hives around his face, arm and chest area. Patient was told to lie down on the floor and we elevated his legs. At this point, pt was still reporting no trouble breathing, but still felt hot around his arm, face, and chest area. An ice pack was placed around his face and neck which helped a bit. Patient kept describing a sensation of tightness and heaviness around his left arm and  fingers . We continued to observe the patient for another 30 minutes till paramedics arrived to take the patient to a nearby hospital.
Itching; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 41-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection), dose 1 via an unspecified route of administration, on 18Mar2021 (Batch/Lot number was unknown; Expiry date was unknown) as dose 1, single for covid-19 immunisation (at the age of 41-year-old). The patient medical history included autoimmune disorder from an unknown date and unknown if ongoing. The concomitant medication included pyridostigmine bromide (MESTINON) taken for an unspecified indication, start and stop date were not reported. On 18Mar2021, within couple of minutes of vaccination, patient experienced a slight reaction to it. It was not a big reaction, just had some itching and she was tried to figure it out. The patient does not wish for second shot because of the itching. She was enquired about the event as considered as a side effect or is that considered to be a reaction. The patient took Benadryl for the treatment of events. The outcome of the events was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Side effects last 4 to 5 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects last 4 to 5 days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects last 4 to 5 days). At the time of the report, VACCINATION COMPLICATION (Side effects last 4 to 5 days) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.
Started with intense jaw-clenching--still ongoing. Then 3 weeks later intense arthritis flare-up involving both knees, left shoulder, elbow, thumbs. Unable to leave my house and am using a wheelchair as I can't stand for more than 10 -15 seconds at a time-Ongoing.  I was ambulatory, using a cane for assistance, prior to receiving the 3rd covid booster shot.
This spontaneous report as received from a Registered Nurse refers to a patient of unknown age and gender. Concurrent conditions and medical history were not reported. The nurse informed that on an unknown date, the patient received the first dose of PROQUAD (Merck) Subcutaneous Injection (dose, route, lot # and expiration date not reported). Later, on an unspecified date in August 2014, they received the second dose of PROQUAD (Merck) Subcutaneous Injection (lot # K007797, expiration date: 29-NOV-2015; dose and route not reported). Then, on an unspecified date in July 2015 (reported as "which was 11 months after administration of the patient's 2nd dose"), the patient was inadvertently vaccinated with a third dose of PROQUAD (Merck) Subcutaneous Injection (lot # L004007, expiration date: 05-AUG-2016; dose and route not reported). All three doses were given. No adverse effect was reported and no PQC was involved. Additional information has been requested.
pt recv vax 20JUL95 & 2wk later exp bilat leg muscle soreness & weakness;events resolved w/in a few weeks untreated;
pt recvd vax 15JUN93 & 16JUN93 seen in ER for immun reaction; pt had swelling & fever evening following immun in lt arm; reaction to tx given @ ER & returned for further treatment; had rash on 5th day & was unhappy w/MD & hosp ER & returned
Swelling on left lateral chest and left flank; Soreness on left lateral chest and left flank; swollen lymph node in left anterior neck; This is a spontaneous report from a contactable consumer, the patient. An 18-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0161) via an unspecified route of administration in the arm left on 16Apr2021 at 12:30 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies. Concomitant medications included protein powder received within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 00:00, one and half day after vaccine, the patient experienced, soreness and swelling on left lateral chest and left flank. The patient did not have redness or warmth, swelling on arm or axilla; swelling and tenderness on left side had increased over the last few days; also swollen lymph node in left anterior neck. The events resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling on left lateral chest and left flank, soreness on left lateral chest and left flank and swollen lymph node in left anterior neck was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Shot given right triceps and reported within 24 hrs a very significant 3 x 8 inch redness, tenderness and swelling starting at the injection site and spreading downward almost to the elbow.  There was no sign of infection and the patient denied any other symptoms.  I saw the site on 10/17/08 and it appeared to me to be a much larger than expected reaction compared to those I have seen in 25 years of giving and receiving flu shots.  I agreed that there was no sign of infection.  The patient has taken flu shots for many years and never reported any similar reactions. We are wondering whether she should now consider herself allergic to all flu vaccines and whether she should get flu vaccines ever again.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 12Jun2022 as dose number unknown, single (Batch/Lot number: unknown) at the age of 72 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: At Day 10, Covid symptoms recurred indication=Treatment of COVID-19. Therapeutic measures (Paxlovid) taken as a result of drug ineffective, covid-19.  Clinical course: Patient received Paxlovid taken from 17Jun2022 to 21Jun2022 for treatment of COVID-19. At Day 10, Covid symptoms recurred. Adverse event start date: 26Jun2022 (as reported). Known allergies: Not that patient known of.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Never received her second administration of the vaccine and is far outside the allowed time window to do so; Fever of 102 degrees Fahrenheit; Fatigue; Hallucinations; Bones aching; loss of appetite; Foggy feeling in head; This spontaneous case was reported by a consumer and describes the occurrence of HALLUCINATION (Hallucinations) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included WARFARIN, METOPROLOL SUCCINATE (TOPROL) and DIGOXIN for an unknown indication.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced HALLUCINATION (Hallucinations) (seriousness criterion medically significant), BONE PAIN (Bones aching), DECREASED APPETITE (loss of appetite), FEELING ABNORMAL (Foggy feeling in head), PYREXIA (Fever of 102 degrees Fahrenheit) and FATIGUE (Fatigue). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Never received her second administration of the vaccine and is far outside the allowed time window to do so). At the time of the report, HALLUCINATION (Hallucinations), BONE PAIN (Bones aching), PRODUCT DOSE OMISSION ISSUE (Never received her second administration of the vaccine and is far outside the allowed time window to do so), PYREXIA (Fever of 102 degrees Fahrenheit) and FATIGUE (Fatigue) had resolved and DECREASED APPETITE (loss of appetite) and FEELING ABNORMAL (Foggy feeling in head) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2020, SARS-CoV-2 test: positive (Positive) positive for the COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product includes chlorizide. Treatment information was not provided. Expiry date reported as unknown.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
spiking of his blood pressure; sore arm; legs swollen; pain on one leg; on and off nausea; not feeling right; This is a spontaneous report  from a contactable consumer (patient). A 77-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration on 24Feb2021 (Lot number was not reported) at the age of 77 years, as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included BNT162B2, dose 1 on unspecified date for COVID-19 immunization. On an unspecified date the patient experienced spiking of his blood pressure, sore arm, legs swollen, pain on one leg, on and off nausea, not feeling right.  The patient had lab tests and procedures which included blood pressure measurement: 190/80.  The clinical outcome of the events was unknown. The clinical course was reported as follows: 77-year-old caller reported receiving his second dose of the Pfizer-BioNTech COVID-19 vaccine 24Feb2021 and experienced a "sore arm" after. He explained that a week after vaccination, on the Monday, he " woke up with his legs swollen and pain on one leg". He stated he also experienced spiking of his blood pressure (BP), however on Monday 03Mar2021 he went to the ER since his BP rose over 190/80. He explained at the ER, he guessed they got him more call, and he received a prescription of "water pills" to take for "a couple weeks".  He added then, there were moments when he "didn't feel right". He specified he would be "good" in the morning then he "just didn't feel right" in the afternoon. He reported about a month later, 13Apr2021 he had a "second incident with the spiking" of his BP, which led him to the ER. He explained his cardiologist then changed his amlodipine prescription to "5mg in the morning and 5mg at night". He explained he would take 1 pill of Amlodipine 10mg in the morning before vaccination. He added he would take 5mg of amlodipine for a year before being increased to that 10mg a day.  He explained before vaccination, he "never experienced such spiking with his BP and considers himself healthy for his age. DSU agent reported his BP is generally around 120/70 and he routinely use the treadmill. He mentioned he now seems ok, has not have a "violent" BP spike, but has "not felt 100%" yet. He added some days he is "fine" and others he has "on and off nausea" or he "feels his legs are swollen in the evening". The main reason for his call is to see if Pfizer have any experience with people who have covid, the long haulers, with the effects for quite a while, that are 3 months in. He was wondering whether or not any long hauler folks that have had on and off side effects attributed it to the vaccine.    Information about Lot Batch number has been requested.
dizzy spell; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EL3302) via an unspecified route of administration in the left arm on 29Jan2021 at 13:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and heart disease. The patient had no known allergies. It was reported that the patient received unspecified medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EK9231) via an unspecified route of administration in the right arm on 08Jan2021 at 09:00(at the age of 68-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 14March2021 at 08:00, the patient experienced dizzy spell. It was reported that the patient had slight dizziness spells. It was reported that 2 about a week ago and 2 today (24Mar2021). Does not last very long, only a couple moments. The patient reported that never had dizzy spells before. No therapeutic measures were taken for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of dizzy spell was recovered on an unspecified date Mar2021.    No follow-up attempts are needed. No further information is expected.
Rash on right thigh started the morning after receiving her first pentacel vaccine. No other symptoms were noted.
This case was reported by a healthcare professional and described the occurrence of injection site redness in a 15-month-old male subject who was vaccinated with Infanrix, GlaxoSmithKline. The subject had no adverse events following receipt of prior immunizations. The subject had no pre-existing medical conditions. The subject's concurrent conditions were not reported. There were no concurrent medications. On 09 March 2007 at 9:00 a.m., the subject received 4th dose of Infanrix in the right arm. On 09 March 2007, the subject also received injections of PedvaxHIB (Merck) and Prevnar (Wyeth Labs) at unspecified sites of administration. Approximately "24 to 48 hours later," on an unspecified date in March 2007, the subject experienced redness and edema at the injection site of the Infanrix administration. The reporter considered the events to be due to potential quality issue for this lot of Infanrix. The events resolved on an unspecified date on or before 14 March 2007. No treatment was required.